| Author |
Title |
Year |
Publication |
Volume |
Pages |
| Celiku, O.; Tandle, A.; Chung, J.-Y.; Hewitt, S.M.; Camphausen, K.; Shankavaram, U. |
Computational analysis of the mesenchymal signature landscape in gliomas |
2017 |
BMC Medical Genomics |
10 |
13 |
| Jensen, S.S.; Petterson, S.A.; Halle, B.; Aaberg-Jessen, C.; Kristensen, B.W. |
Effects of the lysosomal destabilizing drug siramesine on glioblastoma in vitro and in vivo |
2017 |
BMC Cancer |
17 |
178 |
| Brown, D.V.; Filiz, G.; Daniel, P.M.; Hollande, F.; Dworkin, S.; Amiridis, S.; Kountouri, N.; Ng, W.; Morokoff, A.P.; Mantamadiotis, T. |
Expression of CD133 and CD44 in glioblastoma stem cells correlates with cell proliferation, phenotype stability and intra-tumor heterogeneity |
2017 |
PloS one |
12 |
e0172791 |
| Ludwig, K.; Kornblum, H.I. |
Molecular markers in glioma |
2017 |
Journal of Neuro-Oncology |
|
|
| Alshehri, M.M.; Robbins, S.M.; Senger, D.L. |
The Role of Neurotrophin Signaling in Gliomagenesis: A Focus on the p75 Neurotrophin Receptor (p75NTR/CD271) |
2017 |
Vitamins and Hormones |
104 |
367-404 |
